Healthcare -
Biotechnology - NASDAQ - US
$ 19.94
-0.697 %
$ 1.58 B
Market Cap
-4.62
P/E
VRDN - TOTAL RECEIVABLES
Total Receivables VRDN - Viridian Therapeutics, Inc.
102 K
LAST VALUE
-52.44%
2 YEAR CAGR
33.56%
5 YEAR CAGR
-20.36%
10 YEAR CAGR